New Express COVID-19 Testing Service with next day results launched in Dublin
New Express COVID-19 Testing Service with next day results launched in Dublin
New Express COVID-19 Testing Service with next day results launched in Dublin
06 November 2020: New Express COVID-19 Testing Service with next day results launched in Dublin
A new express COVID-19 testing service has now launched in Ireland, with a rapid next day delivery of results.
From global diagnostics provider Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, the service utilises a robust and reliable method of testing known as PCR, the only method recognized and approved for travel testing.
The PCR testing, which Junior Minister for Transport Transport Hildegarde Naughton described as “the gold standard,” is available in Dublin for pre-travel clearance, or simply for those wanting a COVID-19 test for peace of mind.
Sophie Boyd, Project Manager for the Randox Express COVID-19 Testing Service, explained;
“We appreciate that many people will want a COVID-19 test before travelling home this Christmas, or equally, will want a negative test result to reduce quarantine times and enable them to spend more time with loved ones.
“PCR testing is currently the only method of COVID-19 testing which is recognised by every country worldwide. Our rapid, accurate and reliable testing service, used already by a range of well-known companies, airlines and elite sporting organisations, will help get plans off to a hassle-free start for travellers and non-travellers alike.”
The launch of the Randox testing service comes just as Ireland aligns itself with the new EU ‘traffic light’ system to co-ordinate international travel, on Sunday 8th November.
The Government has agreed that, whilst those arriving from red zones currently have to quarantine for 14 days, this could soon be waived following a negative test result from a COVID-19 test taken five days after arrival in Ireland.
Sophie continued;
“Travel requirements during the pandemic continue to evolve, but with the introduction of the EU traffic light system, a common prerequisite will be a negative PCR COVID-19 test prior to travel or to shorten quarantine periods.
“We have significant capacity in place to implement high volume testing and with our PCR testing service, we look forward to supporting the travel industry’s enormous efforts to restore public confidence in international travel.”
The Randox Express COVID-19 Testing Service is priced at €99, is open to all asymptomatic individuals and operates from the Clayton Hotel in Dublin.
Visit booking.randox.ie to book your appointment.
For further information please email info@randoxhealth.com or phone 0800 2545 130.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
Official comment on extension of COVID-19 testing contract
OFFICIAL RANDOX STATEMENT: EXTENSION OF COVID-19 TESTING CONTRACT
Acknowledging the extension of Randox’s contract to provide COVID-19 testing within Pillar 2 of the UK’s National Testing Programme, Randox Founder and Managing Director Dr Peter FitzGerald said;
“We take very seriously our responsibility to ensure that vital laboratory testing for Covid-19 continues and expands during the winter months.
“We have extensively ramped up our capacity and made significant private investment in order to fulfil and exceed our commitment to the National Testing Programme. All at Randox are fully committed to supporting the programme, and we look forward to continuing to play our role, which is crucial to the economic and social wellbeing of the nation.”
Press enquiries should be emailed to randox@newcenturymedia.co.uk
Randox in the media
Latest News
FAQs
Randox & Bosch Healthcare – Collaboratively Combating COVID-19
29th October 2020
Randox & Bosch Healthcare – Collaboratively Combating COVID-19
A game-changing partnership between Randox Laboratories and Bosch Healthcare Solutions continues to change the testing landscape and capabilities of both laboratory and non-laboratory settings in rapidly detecting COVID-19.
Providing clear and concise results, direct at the point of care, the Randox and Bosch Healthcare Solutions collaborative approach not only allows patients to take the recommended safety precautions without delay, but also provides a solution to both analyse and differentiate COVID-19 from other viral respiratory diseases. Multiple testing approaches with the same aim – to overcome COVID-19!
Combining science & technology, timing is of the essence in the fight against coronavirus. Together, we have combined efforts in successfully launching the Vivalytic – the all in one solution for molecular diagnostics consolidating nucleic acid extraction, polymerase chain reaction (PCR) and detection onto one small platform.
These efforts reflect a global partnership of both cooperation’s working together to deliver world-class diagnostic solutions, harnessing the power of innovation to improve health worldwide, providing an all in one approach minimising the spread of COVID-19 globally.
Launched after just six weeks at the beginning of the COVID-19 pandemic back in March 2020, the Viral Respiratory Infection array (VRI) set the benchmark for rapidly detecting SARS-CoV-2 (COVID-19) whilst simultaneously differentiating between nine other respiratory diseases, in under two and a half hours.
Proactively working together to combat the spread of COVID-19, Randox, Bosch Healthcare Solutions and R-Biopharm are proud to offer variable analysis strategies to detect SARS-CoV-2 (COVID-19). Capable of providing reliable results in just 39 minutes, with a sensitivity of 98% and specificity of 100%, the Vivalytic SARS-CoV-2 rapid test is currently among one of the fastest PCR tests worldwide.
Since the outbreak of COVID-19, we have significantly combined our efforts to provide a diverse range of testing solutions and approaches to meet the need of the rise in global cases. Our approaches have been utilised at all possible levels and together we open up a range of different testing strategies, with developments still underway with the upcoming release of the SARS-CoV-2 Pooling test.
The SARS-CoV-2 Pooling test is a rapid solution for the detection of SARS-CoV-2 (COVID-19) offering an accelerated decentral testing approach to effectively and efficiently monitor and detect viral infection from the offset. Capable of detecting SARS-CoV-2 (COVID-19) from up to five pooled samples simultaneously with a capacity to process more than 160 patient samples a day. The pooling could be done at the level of a ward, medical specialty, social bubble, or group of colleagues. It has potential for use in other settings, such as pre-operative screening, schools & universities, prisons, nursing homes, primary care, and large workplaces. Sample pooling allows more people to be tested quickly using fewer testing resources.
Partnering together, we continue to increase our testing capacity, enabling fully automated processing of patient samples to rapidly combat COVID-19.
Please contact marketing@randox.com for further information.
Randox in the media
Latest News
FAQs
Randox response to comments within Sunday Times article 18th October 2020
Randox response to comments within Sunday Times article 18th October:
Randox rejects comments made in the Sunday Times on 18th October, related to Randox’s contribution to the UK’s Covid-19 national testing programme, as misleading and inaccurate.
Randox have committed, through private investment, to the rapid growth of Covid-19 testing capacity within the UK. Indeed Randox are successfully operating at considerable scale and are currently providing well in excess of the testing capacity we have committed to the UK’s testing programme.
The vast majority of samples are reported within 24 hours of entering our laboratories.
Those samples that are found to be unsuitable for processing on receipt at our facilities, and are therefore voided, are not the responsibility of Randox. Such samples are voided when issues have arisen during sample collection and logistic processes, controlled by other parties.
It should also be noted that the proportion of samples found to be unsuitable on receipt at our facilities are both very low and comparable with all other laboratories across the programme.
Randox remain committed to supporting the UK’s Covid-19 testing programme and fully understand the importance of our work to the social and economic well being of the nation.
Press enquiries should be emailed to randox@newcenturymedia.co.uk
Randox in the media
Latest News
FAQs
Randox delves into the inner workings of a racing driverās body and mind for first-ever Goodwood SpeedWeek
13 October 2020
Randox delves into the inner workings of a racing driver’s body and mind for first-ever Goodwood SpeedWeek
Goodwood SpeedWeek will bring fans closer to the action than ever before with a one-off digital technology playground that viewers can experience from the comfort of their own homes – and Randox will feature as part of the event with a documentary showing the inner workings and hidden brilliance of a racing driver’s mind and body under stress.
Being shown on Saturday 17 October, ‘The Racing Mind’ documentary looks at the psychological, physiological and chemical make up of racing drivers.
Millions of spectators will be able to enjoy 360-degree audio-visual displays, take a virtual paddock tour, use chatroom functionality to question their favourite drivers, and interact with the action through quizzes, polls, competitions and a ‘podium predictor’.
Goodwood Speedweek, which runs from 16-18 October 2020, is the most ambitious event to ever take place at the Goodwood Motor Circuit with more than 12 miles of high-speed fibre cabling being laid and 49 high-definition cameras installed, including 19 trackside cameras and 15 live on-boards. A television crew of 180 operators will help bring the action to life with 10 presenters and two TV studios required to cover all the action.
Each day will be dedicated to celebrating the automotive industry’s past, present and future – bringing together the best elements of the Festival of Speed and Revival using the latest technology.
This will be reflected in the iconic Goodwood Shootout presented by Mastercard on Sunday 18 October, with a winner-takes-all one-lap competition between some of the fastest machines in motorsport across the years, including hypercars, single-seaters and prototype sports cars.
The Duke of Richmond said;
“Technology is a core feature of Goodwood motorsport events and we strive to showcase the most innovative and forward-thinking mobility innovations. At Goodwood SpeedWeek we were presented with a unique opportunity to go one step further, quite literally placing digital right at the heart of the experience. It’s allowed us to raise the bar even higher, offering a once in a lifetime, interactive experience that is accessible to viewers anywhere in the world.”
The Racing Mind (Saturday 17th October)
In partnership with Randox, Goodwood Speedweek will show viewers the inner workings and hidden brilliance of a racing driver’s mind and body under stress.
The Technology Showcase (Sunday 18th October)
- The first autonomous lap: Einride will undertake an autonomous lap on the Goodwood Motor Circuit including a behind-the-scenes look at how it was achieved.
- F1 Technology: Before taking to the track to celebrate 70 years of F1, there will be a live grid walk of cars charting the evolution of technology in F1 through the ages.
- Car vs Bike vs Drone: An all-electric race between the Virgin Formula E, Electric Harley and Drone racer on the Driftkhana course.
- Jet Suit: A look behind-the-scenes of Gravity and how you train to become a jet suit pilot, followed by a unique race between three jet racers.
- Ford Electric Mustang: The all-electric Mach-E Mustang 1400 prototype will take to the track for a drift demonstration.
- Sennheiser: An interactive demonstration of 360-degree binaural audio, live from the heart of the event.
Fans can sign up for alerts at: https://www.goodwood.com/motorsport/goodwood-speedweek/
As well as streaming options through goodwood.com and social media, SpeedWeek will be broadcast live on ITV1 and ITV4 during the event;
- Friday 16th Oct – 16:30-18:30 (ITV4)
- Saturday 17th Oct – 14:00-16:00 (ITV4)
- Sunday 18th Oct – 14:00-16:00 (ITV1)
A selection of highlight programmes the week after the event on ITV4;
- First Glance – Wednesday 21st Oct – 21:30
- Highlights 1 – Thursday 22nd Oct – 20:00
- Highlights 2 – Thursday 22nd Oct – 21:00
Stay up to date with all future announcements and on-event action with the official hashtag #gwspeedweek across Goodwood social channels:
- @GoodwoodRRC (Twitter)
- Goodwood Road & Racing (Facebook)
- @goodwoodrrc (Instagram)
Want to know more?
Contact us or visit our Randox Health page to view more.
Our Randox Health programmes
Everyman
Everywoman
Signature
Specialised testing
Prime Minister Boris Johnson congratulates Randox
Prime Minister Boris Johnson congratulates Randox in House of Commons 22 Sep 2020
On Tuesday 22nd September 2020, in the House of Commons, Prime Minster Boris Johnson congratulated Randox for our vital role at national level in helping to deliver the Government’s testing programme.
The statement from the Prime Minister came in response to Sir Jeffrey Donaldson MP, who asked the Prime Minister if he would commend Randox for the work we have done. Sir Jeffrey Donaldson MP said;
Randox has committed 99% of its Covid testing capacity to that programme and on 19th September they successfully reported almost 10,000 samples beyond the recommended daily rate.
The Prime Minister responded by saying;
I do indeed congratulate Randox and all the other businesses involved and we are massively expanding testing the whole time.
Many thanks again for your ongoing support.
Our staff are our best asset and we salute your hard work and commitment.
For further information please email randoxpr@randox.com
Randox in the media
Latest News
FAQs
Matt Hancock pays tribute to Randox staff in House of Commons
Matt Hancock thanks Randox staff in House of Commons 21 September 2020
On Monday 21st September 2020, in the House of Commons, Secretary of State for Health and Social Care, the Rt Hon Matt Hancock MP, personally thanked Randox staff for the role we play within the National Testing Programme.
He said;
Randox deliver a very significant number of tests every single day – a growing number – in fact, they are currently outperforming the allocation we have asked them to deliver and I pay tribute to every single person who works at Randox for the work that they have done and the part that they have played in keeping people safe.
Because everyone who gets a Randox test result, like every other test result, gets more information with which they can keep themselves safe and we have more information with which we can try to keep the whole of society safe.
Our work has greatly expanded the capacity for testing in the UK and we will continue to ramp up our capabilities, to both save lives and promote a timely return to a more normal society.
We thank our staff for their ongoing support, and for their commitment to the work that we do, which is making a real and positive difference.
For further information please email randoxpr@randox.com
Randox in the media
Latest News
FAQs
Randox response to Sunday Times Article 20 September 2020
STATEMENT FROM RANDOX: 20 September 2020
Key Points:
- Randox has committed 99% of its Covid-19 testing capacity to the national testing programme.
- Randox are fully committed to the national testing programme and robustly refute accusations within today’s Sunday Times.
- On 19th September Randox successfully reported to the national programme almost 10,000 samples beyond its committed daily rate.
- The majority of samples which are voided at Randox are down to logistical reasons outside Randox’s control. Samples voided at Randox’s laboratories are comparable to other laboratories across the programme. Every voided sample is properly accounted for.
- Randox does not prioritise private samples over comparable samples within the testing programme.
- Randox staff have performed extraordinarily well and are our strongest asset.
- All Randox investment in rapidly increasing capacity to the national testing programme has been through its own private resources.
Randox are fully committed to supporting the national Covid-19 testing programme and fully recognise the importance of this work to the economic and social well-being of the nation. We have made significant private investment to increase capacity and drive process improvements. We work very closely with all partners within the programme to ensure the most effective possible testing.
Randox robustly refutes accusations in today’s Sunday Times (Sunday 20th September 2020) that private samples are prioritised over comparable samples within the national testing programme.
This is a gross mis-representation of the facts on the ground with regard to its processes.
We reiterate that Randox does not prioritise private samples over comparable samples from the national testing programme.
Once processed into Randox’s laboratories the vast majority of all samples are reported on within 24 hours. It is inaccurate and unreliable to claim that Randox has completed fewer than one in 10 tests on time. In fact Randox is successfully meeting and exceeding the capacity requirements agreed with Government and fulfilling its contractual obligations. Moreover Randox is successfully reporting above our commitment to Government for the national testing programme.
On average the Randox void rate is comparable across the programme. It is important to note that whilst all laboratories conduct the voiding of samples, the reason for the voiding most frequently lies outside the laboratory – normally user or logistic type issues. It is extremely inaccurate and misleading to claim that Randox, or indeed any laboratory, voids samples without explanation.
Every sample is receipted in accordance with stipulated, formal procedures and processed accordingly. This includes cross-referencing every sample barcode electronically with the national registration database. Every sample is appropriately accounted for and samples will only be voided if, due to the quality of the sample, the results could not be guaranteed as reliable. Every sample is fully assessed and if voided is allocated a formal reason for void, and all void statistics are reported daily to Government for further analysis.
It is important to note that Randox is not responsible for the sample logistics of the national programme and, as requested by the national programme, often receives samples in excess of daily capacity to report on within the following days. This is manageable given the time that samples remain valid.
Randox is a private sector diagnostics company, has been in operation since 1982 and operates in 145 countries across the globe. As such Randox have experience of a wide range of public and private sector responsibilities. Randox takes great care in meeting all of its contractual obligations and fully recognises the critical importance of meeting those obligations with regard to the national testing programme.
Randox does not prioritise commercial work ahead of other work streams.
As stated to the Sunday Times, staffing levels are not an issue and holidays have not impacted on throughput – Randox is currently successfully above our commitment to government.
We reiterate that Owen Paterson MP has played no role in securing any Randox contract with DHSC.
Randox staff have been extraordinary in their commitment and dedication in meeting unparalleled need at a time of national crisis, often in the face of ill-informed and misplaced criticism. We salute our staff.
Press enquiries should be emailed to randox@newcenturymedia.co.uk
Randox in the media
Latest News
FAQs
Vacancies available in support of the COVID-19 National Testing Programme
17 September 2020
Vacancies available in support of the COVID-19 National Testing Programme
Vacancies available in support of the COVID-19 National Testing Programme
There’s no doubt that coronavirus is having a devastating effect across the globe.
But here in Northern Ireland there’s a company making a real impact in the fight against COVID-19. And you can be part of it.
Randox Laboratories, in County Antrim, has partnered with the government on its programme for coronavirus testing across Northern Ireland, England, Scotland and Wales.
The programme, which in its first few weeks was focused primarily on staff working within the NHS, and then on key workers, is now available to anyone living across the UK who has symptoms of coronavirus.
Randox are providing high volume laboratory testing of potential COVID-19 samples in its laboratories at the Randox Science Park in Antrim.
It’s an enormous task, but one that Randox is well-equipped to handle. In 2019, Randox manufactured over 3 billion tests and exported to 145 countries. Its new headquarters, the result of a £161 million investment, houses state-of-the-art laboratories and the latest innovations in health diagnostic technology.
The company stepped up to support the government’s testing programme without hesitation.
Across the COVID-19 testing process, a multi-disciplinary team work collaboratively and assiduously to provide optimal support to the national response to COVID-19.
It begins with the production of Randox’s Biochip, a patented testing technology which can run multiple diagnostic tests simultaneously.
Upon identifying the latest strain of coronavirus as a significant global threat, and by drawing on almost 40 years of experience as a world-leading diagnostics company, Randox developed a new Biochip for the diagnosis of COVID-19 in a greatly accelerated time frame of just two weeks. The new Randox Biochip processes two coronavirus tests simultaneously – one specific and one confirmatory – as recommended by the World Health Organisation.
The firm’s team of talented scientists continue to develop these COVID-19 Biochips on an unparalleled scale, in preparation for testing of samples from across the UK.
Meanwhile, specialist engineers design and build the coronavirus testing platforms used to conduct the tests when they arrive at the laboratory.
Randox recently announced it was hiring 160 mechanical, electrical and manufacturing engineers to work on the fast-tracked development of newly designed molecular analysers used to detect the presence of COVID-19.
And the company is also recruiting for positions in Manufacturing and Science, and in particular scientists who have experience in a diagnostic laboratory, in support of Randox’s role within the government testing programme for COVID-19.
These scientists will be exposed to molecular testing techniques including DNA extraction, PCR techniques and Biochip technology, in order to process samples that arrive at the laboratory for testing.
Everyone at Randox has a vital role to play in the practical application of COVID-19 testing. For Scientists, Engineers and those with experience in Manufacturing, Randox’s recruitment drive is a unique opportunity to make a positive impact in the fight against COVID-19. Successful applicants will contribute directly both to saving lives and assisting the national recovery from the COVID-19 pandemic.
To find out more about the positions available for Randox’s COVID-19 testing project, visit https://randox.getgotjobs.co.uk/
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
Randox response to Sunday Times Article 13 September 2020
STATEMENT FROM RANDOX: 13 September 2020
Randox analyse samples and provide Covid-19 test results through the national portal as efficiently as possible, and those tested will receive their results by text and email. The vast majority of those tested will receive negative or positive results.
Otherwise, a small minority of samples may be voided for reasons such as leaking or damaged tubes, or have time expired. Those being tested are made aware that samples only remain valid for a limited period once collected, and those periods of validity are fully understood across the planning and logistic process. Randox have no responsibility for the logistics of sample delivery to laboratories.
Should samples enter the laboratory outside that period the results could not be relied upon; the sample could give a false result and would be voided. In all void circumstances individuals are advised by the national program to seek a retest. Randox, and the Government planners, take every precaution possible to minimise voids, understanding that each sample is of critical importance.
A test can only be voided once it is processed and reviewed within our laboratory system, including cross referencing each barcode electronically with the national registration database.
Randox Laboratories are committed to supporting the Government’s response to the Covid-19 pandemic and play an important role in national network of Pillar 2 (outside the NHS) laboratories testing those who may be currently infected with Covid-19. Such testing is critical to the timely identification and containment of Covid-19 outbreaks and to reduce further spread. It is acknowledged that the success of the testing program is essential to the social and economic well-being of the nation.
To support our operations Randox liaise very closely with Government planners responsible for the national collection and distribution of samples, and have built an additional 30,000 square feet of laboratory space and employed many more staff in order to increase capacity. At the time of writing further increases in capacity are being implemented and planned. Decisions on sample distribution across the Pillar 2 laboratory network are made at a national level.
Randox remain committed to effective and timely Covid-19 testing at scale – this is work of national importance.
Press enquiries should be emailed to randox@newcenturymedia.co.uk